Researchers at the University of South Australia have developed a novel, biodegradable gel for Parkinson's disease treatment.

Parkinson's disease is a neurogenerative disease that affects more than 1 million people in the U.S. While some cases are ...

Researchers at Northwestern Medicine have discovered that a virus that has flown under the radar for years might be a ...

Looking a treatment for symptoms of decline in thinking and reasoning skills? Recent study approves common cough syrup to ...

A progressive neurological disorder affecting 10 million people globally, Parkinson’s can cause disruptive symptoms such as ...

Researchers have developed a long-acting weekly injection that delivers steady doses of levodopa and carbidopa, potentially transforming care for Parkinson’s disease.

July 9 (UPI) -- A common virus once thought harmless to humans might be linked to Parkinson's disease, a new study says. The ...

New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

Parkinson's disease is the second most common neurodegenerative disorder, affecting 2% to 3% of adults aged 65 or older. The disorder is not fatal, but it's incurable and can severely impact your ...

Kerry Huntington counts out loud each punch she hurls at the speed bag in front of her, keeping her eyes trained on the ...

Learn about the key symptoms of Parkinson's disease, including tremors, weakness, and walking difficulties. Understand their impact and what to expect for better management.

A once-a-week Parkinson’s injection could replace multiple daily pills, thanks to a new slow-release formulation developed by ...